Recent literature has described the exciting development of a new universal detection technology for high-performance liquid chromatography (HPLC), as well as some exploratory work on its application to quantitative measurement of solutes at millimolar concentrations. The new methodology, known as charged aerosol detection (CAD), has been recognized as a viable alternative to evaporative light-scattering detection and refractive index detection that, like CAD, respond to molecular structures independently of their absorbance, or lack thereof, in the ultraviolet region of the electromagnetic spectrum. In this article, the authors exemplify their use of CAD in-line with HPLC and mass spectrometry (MS) to provide both standalone and complementary information that aids decision making for sample storage and processing practices in the compound management setting. Illustrations include monitoring contaminants leached from different plate materials into the solvent dimethyl sulphoxide (DMSO) and profiling the concentrations of solutions destined for liquid storage and dispensing to assays, with the aim of improving processes. (Journal of Biomolecular Screening 2009:531-537) 
INTRODUCTION
O n a "wish-list" for quality assurance laboratories, the ideal detector for the quantitative measurement of a compound eluting from a liquid chromatography (LC) column would show high sensitivity to all types of compounds, with a proportional response for each compound, including a reference standard, according to their relative abundance.
The required sensitivity is commonly achieved for highthroughput LC of pharmaceutical compounds by measuring ultraviolet (UV) absorption. By assuming that all compounds in a mixture have a similar molar extinction coefficient Є in the range of wavelengths scanned (typically 220-300 nm), the relative amounts of each component, and hence purity, are derivable from the peak integrals.
Although drug-like compounds commonly incorporate structural features giving strong UV absorption, such as aromaticity and conjugated double bonds, non-drug-like contaminants may have little or no absorbance in the range of wavelengths studied and may be effectively invisible to the UV detector. Conversely, a contaminant could have a much higher Є value than the compound of interest and thus, from the UV peak integration, be wrongly diagnosed as the dominant component in the sample. What is needed, therefore, is a detector that responds with equal and high sensitivity to any type of compound irrespective of its structure.
Among the alternative technologies explored as LC detectors, the use of charged aerosol detection (CAD) has risen to prominence recently. [1] [2] [3] [4] At AstraZeneca, we have incorporated CAD into the armory of our compound management (CM) quality assurance processes by incorporating detectors in our post-HPLC (high-performance liquid chromatography) outflow alongside the standard mass spectrometry (MS) and UV detectors. This has allowed us to evaluate CAD both as an independent and as a complementary detection technique for tackling a variety of challenges.
The initial cost outlay on equipment for performing CAD analysis will typically add up to 20% of the cost of an HPLC-MS system, the main requirements being the detector itself and an extra gradient pump. After the initial outlay, the additional cost of running CAD alongside LC/MS analysis is negligible. The detector, placed in the path of eluent from an HPLC column, responds to residual charged particulate matter resulting from evaporation of the solvent with concomitant transfer of electrical charge from a cross-flow of ionized nitrogen. 5 In a mixed-solvent nonisocratic HPLC flow, the baseline response of the CAD is affected by the varying proportions of mixed solvents, but it can be stabilized by the introduction of a countergradient post-LC using the same mixed solvents, such that the proportions of each component in the solvent mixture reaching the detector are constant. 2, 6 As each analyte is eluted from the LC column, it gives a CAD response that is proportional to the amount of the compound. Previous work has demonstrated the linear response of CAD, and for compounds with molecular weights above approximately 300 Da, the response is proportional to a weight per volume value, leading to potential quantification by comparison with a calibration standard. 2, 3 
MATERIALS AND METHODS
Dimethyl sulphoxide (DMSO) (analytical reagent grade) was sourced from Fisher Scientific (Loughborough, UK).
HPLC-MS-CAD instrumentation and method
All HPLC was run on an Agilent 1200 system (Agilent, Santa Clara, CA) comprising 2 G1312B ultra-high-pressure binary pumps, a G1315C Diode Array detector, a G1316B Thermostatted Column Compartment, a G1379B Micro De-gasser, a G1367C Micro Well Plate Auto-sampler, a G2255A Extended Well Plate Handler, and a 35900E analog-to-digital converter.
The eluent from the HPLC was split between an Agilent 6140 single quad mass spectrometer equipped with a multimode source and an ESA (ESA, Chelmsford, MA) Corona charged aerosol detector.
HPLC reversed-phase separations were performed on a 30 × 2-mm Gemini 3-µm C18 column (Phenomenex, Torrance, CA) at a flow rate of 700 µL per minute using a gradient comprising (A) HPLC grade water (Fisher Scientific) with 7 mM ammonium acetate (97%; Alfa Aesar, Heysham, UK) and (B) HPLC grade methanol (Fisher Scientific). The conditions for pump 1 were at time 0, A = 90%, with a linear gradient such that after 2 min, B = 100%, which was held for 0.5 min before returning to starting conditions. The gradient conditions for pump 2 were the opposite of pump 1 so as to combine the 2 solvent streams after the column and produce a constant 50:50 volume/volume mix of A and B at the detectors.
The Agilent 6140 MS acquired from 100 to 1000 Da in sequential positive and negative ion modes with a total cycle time of 1 s, and the output from the Corona CAD (ESA) detector was acquired at a rate of 5 Hz through the analog-to-digital converter. The diode array detector (DAD) scanned from 220 to 300 nm at a rate of 20 Hz.
All data were acquired into Chemstation Version B.03.01 (Agilent). The data from the DAD and CAD detectors were integrated automatically within Chemstation. The mass spectra produced for these peaks were compared with the predefined adduct patterns for the mass of interest. These adduct patterns are, for positive ion M+1 (compound plus proton), M+23 (compound plus sodium ion), 2M+1 (compound dimer plus proton), and 2M+23 (compound dimer plus sodium ion). In negative ion mode, the patterns are M-1 (compound minus proton) and M+59 (compound plus acetate ion). Data interpretation and report generation were performed using Analytical Studio Reviewer (ASR) Version B.01.00 (Agilent).
Nuclear magnetic resonance instrumentation and method
All nuclear magnetic resonance (NMR) experiments were performed on a 700-MHz Bruker (Bruker, Bremen, Germany) equipped with a 3-mm cryogenic probe. A standard reference solution was prepared containing 10.5 mg of 4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one (warfarin) dissolved in 3200 µL of DMSO (analytical reagent grade, Fisher Scientific), which contained an internal standard of maleic acid (5.8 mg). Then, 200 µL of the standard solution, to be used for the NMR calibration, was placed in a 3-mm diameter NMR spin tube (Bruker). The remainder was stored in sealed vessels at 10% relative humidity and 20 °C.
Quantitation
The spectral data from the NMR experiment were used to quantify the relative proportions of warfarin, maleic acid, and (undeuterated) DMSO by finding the integral value of 1 proton for each species and comparing their ratios. The density of pure DMSO is 1.1 g per liter, which equates to 14.08 molar concentration. The concentration of the internal maleic acid standard was 15.6 mM. The concentration of warfarin deduced from comparison with the DMSO integral was 9.82 mM, and that from comparison with the maleic acid integral (assuming accurate weighing of maleic acid) was 9.52 mM. It was clear that further work using a statistical design was required to establish the true confidence limits of the concentration values, but for the purpose of exploration, it was concluded from the NMR data that the warfarin concentration was approximately 9.5 to 10 mM in the standard solution.
The residual standard solution of warfarin and maleic acid in DMSO was used for daily calibration of a CAD reference solution that contained only warfarin dissolved in DMSO.
The integrated peak area from the CAD detector is proportional to the weight per volume of analyte present in solution. 5 To convert this to a molar sample concentration, one must compare the analyte peak area with that of the reference compound and adjust for the relative molecular weight (MW) compared to that of the reference. Thus, sample concentration = K (sample CAD area/sample MW), where the constant K is derived from the measurement on the warfarin reference solution and is described by the following relationship: K = reference concentration (reference MW/reference CAD area).
RESULTS AND DISCUSSION

Use of CAD as a qualitative detector for contaminants leached from microplates
Users of plastic microplates are alert to the possibility of contaminants such as plasticizers and stabilizers leaching from the plate polymer into the test solutions in the wells. Clearly, plate types exhibiting minimal leaching are desired, to reduce potential effects on the assay for which the plate is destined. The length of time of storage of solution in plates is also likely to influence the leaching contamination, and it would be helpful to have guidelines for maximum storage times, based on factual evidence.
As part of an ongoing focus on standardization and minimizing cost, the Alderley Park CM group looked at reducing the variety of plate types used for dispensing solutions to biological assays and, while doing so, aimed to select plate materials showing the least tendency to leaching.
For 2 types of plate materials, polystyrene and polypropylene, 31 plate types were evaluated, sourced from different suppliers at various specifications. They included uncoated and coated plates (tissue culture, nonspecific protein binding, and cellbinding surfaces) and with clear, white, and black bases. The list of the 384-well plate types tested is shown in Table 1 . They were foil-sealed and stored at room temperature (20 °C) and 10% relative humidity, with neat DMSO in the wells, for up to a maximum of 3 months. The DMSO was sampled at weekly intervals and analyzed by HPLC-MS-UV-CAD to look for compounds leached from the plate polymer material. It was immediately apparent that, based on LC retention times, diverse contaminants were derived from the various plate types. The experiment was purely qualitative, with the height or area of peak being no indication of quantity because the impurities were unidentified and without an appropriate reference standard. Figure 1 shows observations on 4 examples of plate types in the study, with 1 (polypropylene plate 2) showing several peaks by CAD that were not visible by UV. First traces of impurities began to appear after 3 weeks of storage, prompting a working recommendation to store assay plates containing DMSO solutions for no longer than 3 weeks. On prolonged storage, a UV-absorbing contaminant peak at the same retention time was seen for all the polystyrene but not the polypropylene plates. Several plate analyses showed CAD response peaks that were absent from the UV detector traces and vice versa, highlighting the advantage of using the 2 detection techniques in complementary fashion.
The lowest incidence of contaminant leaching in these experiments, which was observed by the combination of CAD and UV detection, occurred in the 2 UV-transparent plate types supplied by Greiner (781801) and Corning (3675) and 2 polypropylene plate types sourced from Greiner (781201) and Labcyte (P-05525).
Applications of CAD to monitoring concentration of solubilized compound stock
The dissolution of solid compound in DMSO is a routine activity for many CM groups where implicit assumptions are made in aiming at target solution concentration. The purity of the solid, for example, may be accepted on trust from the supplier, but inevitably any impurity has an immediate consequence for the concentration of the expected compound in the solution generated. Precision and accuracy of weigh balances and automation normally control the weighing of the solid and dispensing of the solvent satisfactorily, but ultimately, the solid may not dissolve completely, and often a visual check by an operator will detect this. It was against this background of historical practice, together with an acknowledged need to monitor stored liquid stock concentrations, 7 that we began to use CAD to explore the spread of solution concentrations generated from different sources and handling processes of solid compounds.
For the samples exemplified here, all solids were weighed by hand and then dissolved in DMSO with the intention of preparing a nominal concentration of 10 mM. The solution concentration values were deduced by comparison of the integrated CAD peaks with those of the warfarin reference solution, using the formula described earlier and assuming a warfarin concentration of approximately 10 mM. As the same reference solution was used throughout, the relative shifts in concentration from one measurement to the next would be valid even if the accuracy of the reference concentration was uncertain. Figure 2 shows the concentrations measured for 77 solutions in DMSO created from free-flowing solids that had been submitted to CM with a nominal purity greater than 85% and weighed within CM. These solids were dissolved in vessels that were inverted repeatedly after the solvent was added. The range of apparent concentrations as measured by CAD has a mean value of 8.4 mM with a standard deviation (SD) of 1.6. Inspection of the samples with concentrations less than the mean value revealed no obvious relationship to structural features, the source project or chemist, or predicted properties such as lipophilicity or acidity/basicity, leaving other possibilities such as compound solubility in DMSO to be investigated separately (unpublished data). The frequency graph (Fig. 3) illustrates the fairly tight distribution of this set around the expected concentration. In contrast, the concentrations of 50 solutions created from an assortment of sticky solids and gums are shown in Figure 4 . These samples had been preweighed before receipt in CM and were supplied in a type of vessel that required a vortex mixing process after the addition of solvent. The measured concentrations were scattered widely around a mean value of 6.1 mM with an SD of 3.1. Although there was no obvious precipitate in the dissolving vessel, it was a logical suspicion that the mixing process might not be dissolving relatively "sticky" materials satisfactorily. A simple inverter was therefore designed and constructed for CM that would accept these particular vessels. From the same batch of "sticky" samples, after inversion dissolution, a further random set of 96 solutions was chosen for CAD analysis. The concentrations measured are shown in Figure 5 , with a mean value increased to 8.4 mM (SD 1.8), suggesting that inversion mixing encouraged more efficient dissolution. An inspection of the samples with below-mean concentrations revealed no trends related to the structural scaffold or functionality, the compound source, or predicted physicochemical properties. However, further studies, described next, found a link between synthetic purification technique and solution concentrations.
Solid dissolution processes
Synthetic purification processes
Trends observed in samples emerging from different purification processes have been noticed. Across 20 libraries of compounds, the concentrations of those originally purified by preparative reversed-phase HPLC were consistently higher (mean of 8.5 mM) than those from a recrystallization approach (mean of 7.1 mM), which were in turn higher than those samples from preparative normal-phase thin-layer chromatography (mean of 5.9 mM). Typical contaminants from purification techniques are inorganic salts and silica, which are not amenable to UV detection, so that concentration measurement has enhanced significance here. The choice of purification method at the end of a synthetic route could therefore be linked to sample purpose, with the more costly HPLC approach being justified where higher quality is needed.
Difficult-to-weigh solids
A further opportunity arose to use CAD for correcting concentrations of solutions from unknown weights of samples. The idea originated from handling of a set of samples that were believed to be too impure for creating solutions for the liquid collection. As part of the intended purification process, the solids were weighed and dissolved to a nominal concentration of 87 mM. HPLC-MS-UV-CAD was then used to check their purity, identity, and concentration. Although the impure compounds were selected for the dedicated purification process, the purity of certain solutions was already high and further purification unnecessary, so for these compounds, it only remained to dilute them to the desired 10-mM concentration. The CAD measurement of actual concentration could be used to calculate the volume of additional DMSO needed to bring the concentration down to the target value required. A similar principle can be applied to one of the trickier challenges faced in CM, that of handling small quantities of sticky solids, received in untared vessels, that need to be weighed and solubilized to a target concentration. With very small quantities, there is no option to transfer an accurately weighed amount into a preweighed vessel due to inevitable loss of material in the transfer process. By the addition of a very small volume of DMSO into the original vessel, and thorough dissolution by inversion or acoustic mixing, a solution of high concentration is created. Analysis by HPLC-MS-UV-CAD confirms the identity and purity and provides a measurement for the current concentration. The solution can then be diluted with further DMSO to give the target concentration.
Impact of compound concentrations on biological assay results
Although we observed the variation of concentrations in our liquid stock caused by different solubilization processes and, in other instances, by variability in the original purity of the solids, this needs to be related to the impact on decision making.
For high-throughput screening (HTS) of libraries of compounds where the assay results are clustered by the structural diversity of the compounds, recognition of a lead compound series may not be heavily affected by variations in the concentration, and hence activity, of the stock solutions. However, for follow-up screening and for screens where the data analysis is not dependant on clustering, the concentration of active compound may be more critical. In lead optimization, the intrinsic error of a biological assay may already affect the "ranking" of compounds having similar assay results, and so any further error introduced by inaccurate concentration is deeply unwelcome. Data from an AstraZeneca in vitro fluorescent metabolic inhibition assay (based on an existing in-house methodology 8 ) using recombinant cytochrome P450 enzyme isoforms demonstrated a sensitivity to compound concentration fluctuations that was sufficient to affect the order of ranking of the inhibition constant (IC 50 ) data. Figure 6 shows 3 examples of P450 enzyme isoforms for which the IC 50 has been calculated based on a starting compound concentration of 10 mM, using actual starting concentrations ranging from 2 to 12 mM. In 1 instance (isoform 1), there was high inhibition even at the lowest concentration. In the other 2 instances, the IC 50 calculated when the actual starting concentration was only 2 mM would indicate low inhibition, whereas the true IC 50 at 10 mM starting concentration would indicate moderate to high inhibition. Clearly, then, the correct concentration is imperative for such assays.
As a first step in CM, we are moving toward much closer "just-in-time" monitoring by CAD of the solution concentrations for our secondary screening destinations.
CONCLUSION
The versatility of CAD is beginning to be appreciated and exploited in compound management. Observation of non-UVabsorbing compounds allows better monitoring for potential leaching of contaminants from assay plate materials.
Dissolution processes can be monitored to provide quality and consistency in the outcomes and new approaches devised for handling difficult-to-weigh compounds. The impact on some biological assays of receiving inaccurate concentrations of liquid stocks can start to be addressed and adjusted. 
